프로메디젠 주식회사

{
  "address": "대전광역시 유성구",
  "ceo_name": "박희성",
  "certificate": [
    {
      "cert_number": "20190113476",
      "changes": "",
      "disclosure_date": "2019-11-19",
      "first_cert_date": "2019-11-19",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2019-11-19 ~ 2021-11-18"
    },
    {
      "cert_number": "20211027010037",
      "changes": "",
      "disclosure_date": "2021-10-27",
      "first_cert_date": "2019-11-19",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2021-11-19 ~ 2024-11-18"
    },
    {
      "cert_number": "20241113010034",
      "changes": "",
      "disclosure_date": "2024-11-13",
      "first_cert_date": "2019-11-19",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2024-11-19 ~ 2027-11-18"
    }
  ],
  "company_name": "프로메디젠 주식회사",
  "corp_no": "160111-*******",
  "financials": {
    "2022": {
      "capital_stock": 2014956000,
      "cost_of_sales": 0,
      "current_assets": 5142638000,
      "current_liabilities": 409577000,
      "gross_profit": 0,
      "net_income": -2668406000,
      "net_income_bs": -2668406000,
      "non_current_assets": 1865505000,
      "non_current_liabilities": 164700000,
      "non_operating_expenses": 668489000,
      "non_operating_income": 748649000,
      "operating_profit": -2748566000,
      "revenue": 0,
      "sga_expenses": 2748566000,
      "total_assets": 7008143000,
      "total_equity": 6433865000,
      "total_liabilities": 574278000
    },
    "2023": {
      "capital_stock": 2014956000,
      "cost_of_sales": 0,
      "current_assets": 2786805000,
      "current_liabilities": 1054713000,
      "gross_profit": 0,
      "net_income": -3246486000,
      "net_income_bs": -3246485000,
      "non_current_assets": 1619988000,
      "non_current_liabilities": 164700000,
      "non_operating_expenses": 25055000,
      "non_operating_income": 122275000,
      "operating_profit": -3343706000,
      "revenue": 0,
      "sga_expenses": 3343706000,
      "total_assets": 4406793000,
      "total_equity": 3187380000,
      "total_liabilities": 1219413000
    }
  },
  "industry": "물리, 화학 및 생물학 연구개발업",
  "investment": [
    {
      "amount": "2,000,000,000",
      "changes": "2,000,000,000",
      "date": "2020-03-31"
    },
    {
      "amount": "1,000,000,000",
      "changes": "1,000,000,000",
      "date": "2019-12-19"
    },
    {
      "amount": "1,000,000,000",
      "changes": "1,000,000,000",
      "date": "2019-12-19"
    },
    {
      "amount": "2,000,001,724",
      "changes": "2,000,001,724",
      "date": "2019-12-19"
    }
  ],
  "main_products": "의약용 화합물",
  "phone": "042-867-****",
  "years": [
    2023,
    2022
  ]
}